Related references
Note: Only part of the references are listed.ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1
Nikhil Tyagi et al.
MOLECULAR CANCER RESEARCH (2018)
Critical assessment of methods of protein structure prediction (CASP)Round XII
John Moult et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)
Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-alpha in Hormone-Resistant Breast Cancers
Kriti Singh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
EComputer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer
Lavinia A. Carabet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Toxic Colors: The Use of Deep Learning for Predicting Toxicity of Compounds Merely from Their Graphic Images
Michael Fernandez et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
ETV2 mediates endothelial transdifferentiation of glioblastoma
Chengjian Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin
Tiansuo Zhao et al.
CANCER RESEARCH (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α
Joon Ho Lee et al.
ONCOLOGY REPORTS (2017)
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
Fuqiang Ban et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Pharmacological inhibition of the transcription factor PU.1 in leukemia
Ileana Antony-Debre et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis
Rohit Bose et al.
NATURE (2017)
ETV6 in hematopoiesis and leukemia predisposition
Hanno Hock et al.
SEMINARS IN HEMATOLOGY (2017)
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Ashwani K. Sood et al.
TUMOR BIOLOGY (2017)
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger et al.
BLOOD CANCER JOURNAL (2017)
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
Miriam S. Butler et al.
ONCOTARGET (2017)
ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease
Parisa Rasighaemi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
The ETS family of oncogenic transcription factors in solid tumours
Gina M. Sizemore et al.
NATURE REVIEWS CANCER (2017)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Xiaoju Wang et al.
CANCER CELL (2017)
Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells
Zhongping Cheng et al.
MOLECULAR CARCINOGENESIS (2016)
The oncogene ERG: a key factor in prostate cancer
P. Adamo et al.
ONCOGENE (2016)
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2016)
Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
Vittorio Caropreso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Signatures of prostate-derived Ets factor (PDEF) in cancer
Nitin Mahajan
TUMOR BIOLOGY (2016)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
MZF-1/Elk-1 interaction domain as therapeutic target for protein kinase Ca-based triple-negative breast cancer cells
Chia-Jen Lee et al.
ONCOTARGET (2016)
The ELK3-GATA3 axis orchestrates invasion and metastasis of breast cancer cells in vitro and in vivo
Sun-Young Kong et al.
ONCOTARGET (2016)
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
Hae Hyun Jung et al.
SCIENTIFIC REPORTS (2016)
ELF5 isoform expression is tissue-specific and significantly altered in cancer
Catherine L. Piggin et al.
BREAST CANCER RESEARCH (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
ZINC 15-Ligand Discovery for Everyone
Teague Sterling et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
The role of the transcription factor Ets1 in carcinoma
Juergen Dittmer
SEMINARS IN CANCER BIOLOGY (2015)
The ets transcription factor Fli-1 in development, cancer and disease
Y. Li et al.
ONCOGENE (2015)
Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs
Mei Qi et al.
TUMOR BIOLOGY (2015)
Molecular Pathways: Targeting ETS Gene Fusions in Cancer
Felix Y. Feng et al.
CLINICAL CANCER RESEARCH (2014)
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein
Marius S. Pop et al.
MOLECULAR CANCER THERAPEUTICS (2014)
High-risk prostate cancer-classification and therapy
Albert J. Chang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
Joshua P. Plotnik et al.
NUCLEIC ACIDS RESEARCH (2014)
A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model
Said Rahim et al.
PLOS ONE (2014)
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
Shan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer
J-L Wang et al.
CELL DEATH & DISEASE (2014)
ERG induces taxane resistance in castration-resistant prostate cancer
Giuseppe Galletti et al.
NATURE COMMUNICATIONS (2014)
Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia
Eva Diffner et al.
BLOOD (2013)
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes
Barbara Mesquita et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
ETS Transcription Factor ESE1/ELF3 Orchestrates a Positive Feedback Loop That Constitutively Activates NF-κB and Drives Prostate Cancer Progression
Nicole Longoni et al.
CANCER RESEARCH (2013)
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
Esther Baena et al.
GENES & DEVELOPMENT (2013)
Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
Raja Nhili et al.
NUCLEIC ACIDS RESEARCH (2013)
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Alvaro Aytes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeted therapy for breast cancer prevention
Petra den Hollander et al.
FRONTIERS IN ONCOLOGY (2013)
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Sangphil Oh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features
Domenico Albino et al.
CANCER RESEARCH (2012)
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Daiana D. Becker-Santos et al.
CARCINOGENESIS (2012)
Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors
Longjiang Shao et al.
CLINICAL CANCER RESEARCH (2012)
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma
Aleksandar Boro et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease
Jordan R. Oliver et al.
LABORATORY INVESTIGATION (2012)
Drug-mediated inhibition of Fli-1 for the treatment of leukemia
Y-J Li et al.
BLOOD CANCER JOURNAL (2012)
Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density
Dong-Xia Yang et al.
Chinese Journal of Cancer (2012)
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
A. Pellecchia et al.
ONCOGENESIS (2012)
Genomic and Biochemical Insights into the Specificity of ETS Transcription Factors
Peter C. Hollenhorst et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
TMPRSS2-ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers
Ram-Shankar Mani et al.
CANCER RESEARCH (2011)
ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
Samir Taoudi et al.
GENES & DEVELOPMENT (2011)
Acute myeloid leukemia: A central role for the ETS factor ERG
Joost H. A. Martens
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Mohammad H. Forouzanfar et al.
LANCET (2011)
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
Said Rahim et al.
PLOS ONE (2011)
Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
Patrick J. Grohar et al.
NEOPLASIA (2011)
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Anthony G. Clementz et al.
BREAST CANCER RESEARCH (2011)
Ets2 transcription factor, telomerase activity and breast cancer
Julie M. Dwyer et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
The relationship between early embryo development and tumourigenesis
Yanlei Ma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
P. Burda et al.
LEUKEMIA (2010)
ERG Is a Megakaryocytic Oncogene
Samira Salek-Ardakani et al.
CANCER RESEARCH (2009)
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Jose Luis Ordonez et al.
CANCER RESEARCH (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
E74-like factor 2 transactivates valosin-containing protein gene, a gene involved in cancer growth
Ying Qiu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3-or Erm-dependent transcription
Virginie Firlej et al.
JOURNAL OF CELL SCIENCE (2008)
Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
H. Makkonen et al.
ONCOGENE (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
ETS transcription factors in endocrine systems
Arthur Gutierrez-Hartmann et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype:: A cancer and leukemia group B study
G Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors:: positive links to MMP2, NRG1 and CGB expression
I Bièche et al.
CARCINOGENESIS (2004)
Clinical significance of PEA3 in human breast cancer
J Kinoshita et al.
SURGERY (2002)
Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression
CA Kim et al.
EMBO JOURNAL (2001)
Share Paper
